HEADER TRANSFERASE 22-MAY-19 5QRD TITLE PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF HUMAN ALAS2A TITLE 2 IN COMPLEX WITH Z1328968520 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5-AMINOLEVULINATE SYNTHASE, ERYTHROID-SPECIFIC, COMPND 3 MITOCHONDRIAL; COMPND 4 CHAIN: B, A; COMPND 5 SYNONYM: ALAS-E,5-AMINOLEVULINIC ACID SYNTHASE 2,DELTA-ALA SYNTHASE COMPND 6 2,DELTA-AMINOLEVULINATE SYNTHASE 2; COMPND 7 EC: 2.3.1.37; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ALAS2, ALASE, ASB; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS SGC - DIAMOND I04-1 FRAGMENT SCREENING, PANDDA, XCHEMEXPLORER, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.A.BEZERRA,W.FOSTER,H.BAILEY,L.SHRESTHA,T.KROJER,R.TALON,J.BRANDAO- AUTHOR 2 NETO,A.DOUANGAMATH,B.B.NICOLA,F.VON DELFT,C.H.ARROWSMITH,A.EDWARDS, AUTHOR 3 C.BOUNTRA,P.E.BRENNAN,W.W.YUE REVDAT 2 06-MAR-24 5QRD 1 REMARK REVDAT 1 07-AUG-19 5QRD 0 JRNL AUTH G.A.BEZERRA,W.FOSTER,H.BAILEY,L.SHRESTHA,T.KROJER,R.TALON, JRNL AUTH 2 J.BRANDAO-NETO,A.DOUANGAMATH,B.B.NICOLA,F.VON DELFT, JRNL AUTH 3 C.H.ARROWSMITH,A.EDWARDS,C.BOUNTRA,P.E.BRENNAN,W.W.YUE JRNL TITL PANDDA ANALYSIS GROUP DEPOSITION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.76 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.76 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 80.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 82.6 REMARK 3 NUMBER OF REFLECTIONS : 77025 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.227 REMARK 3 R VALUE (WORKING SET) : 0.225 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 3955 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.76 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.80 REMARK 3 REFLECTION IN BIN (WORKING SET) : 648 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 9.47 REMARK 3 BIN R VALUE (WORKING SET) : 0.3470 REMARK 3 BIN FREE R VALUE SET COUNT : 29 REMARK 3 BIN FREE R VALUE : 0.3800 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6605 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 47 REMARK 3 SOLVENT ATOMS : 248 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.15 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.18000 REMARK 3 B22 (A**2) : -0.17000 REMARK 3 B33 (A**2) : -0.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.08000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.169 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.150 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.118 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.800 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.933 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7678 ; 0.008 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 6526 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10042 ; 1.559 ; 1.635 REMARK 3 BOND ANGLES OTHERS (DEGREES): 15089 ; 1.356 ; 1.568 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 932 ; 6.776 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 385 ;27.852 ;21.351 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1131 ;15.989 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 44 ;19.290 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 909 ; 0.078 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8552 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1724 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3741 ; 2.579 ; 3.217 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 3740 ; 2.577 ; 3.215 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4594 ; 3.642 ; 4.801 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 5QRD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-MAY-19. REMARK 100 THE DEPOSITION ID IS D_1001402310. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-APR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 0.91587 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 80975 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.763 REMARK 200 RESOLUTION RANGE LOW (A) : 71.867 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.76 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 68.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 6HRH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.5, 0.2 M MAGNESIUM REMARK 280 CHLORIDE, 20% PEG3350, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 63.98600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.41550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 63.98600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 54.41550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -62.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B 119 REMARK 465 GLY B 120 REMARK 465 HIS B 121 REMARK 465 HIS B 122 REMARK 465 HIS B 123 REMARK 465 HIS B 124 REMARK 465 HIS B 125 REMARK 465 HIS B 126 REMARK 465 SER B 127 REMARK 465 SER B 128 REMARK 465 GLY B 129 REMARK 465 VAL B 130 REMARK 465 ASP B 131 REMARK 465 LEU B 132 REMARK 465 GLY B 133 REMARK 465 THR B 134 REMARK 465 GLU B 135 REMARK 465 ASN B 136 REMARK 465 GLU B 183 REMARK 465 ALA B 184 REMARK 465 SER B 185 REMARK 465 VAL B 186 REMARK 465 ALA B 187 REMARK 465 ASP B 549 REMARK 465 VAL B 550 REMARK 465 SER B 551 REMARK 465 VAL B 552 REMARK 465 ALA B 553 REMARK 465 ALA B 554 REMARK 465 CYS B 555 REMARK 465 ASN B 556 REMARK 465 PHE B 557 REMARK 465 GLY B 579 REMARK 465 PRO B 580 REMARK 465 GLN B 581 REMARK 465 TYR B 582 REMARK 465 VAL B 583 REMARK 465 THR B 584 REMARK 465 THR B 585 REMARK 465 TYR B 586 REMARK 465 ALA B 587 REMARK 465 MET A 119 REMARK 465 GLY A 120 REMARK 465 HIS A 121 REMARK 465 HIS A 122 REMARK 465 HIS A 123 REMARK 465 HIS A 124 REMARK 465 HIS A 125 REMARK 465 HIS A 126 REMARK 465 SER A 127 REMARK 465 SER A 128 REMARK 465 GLY A 129 REMARK 465 VAL A 130 REMARK 465 ASP A 131 REMARK 465 LEU A 132 REMARK 465 GLY A 133 REMARK 465 THR A 134 REMARK 465 GLU A 135 REMARK 465 ASN A 136 REMARK 465 SER A 182 REMARK 465 GLU A 183 REMARK 465 ALA A 184 REMARK 465 SER A 185 REMARK 465 VAL A 186 REMARK 465 ALA A 187 REMARK 465 ASP A 549 REMARK 465 VAL A 550 REMARK 465 SER A 551 REMARK 465 VAL A 552 REMARK 465 ALA A 553 REMARK 465 ALA A 554 REMARK 465 CYS A 555 REMARK 465 GLY A 579 REMARK 465 PRO A 580 REMARK 465 GLN A 581 REMARK 465 TYR A 582 REMARK 465 VAL A 583 REMARK 465 THR A 584 REMARK 465 THR A 585 REMARK 465 TYR A 586 REMARK 465 ALA A 587 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN B 147 CG CD OE1 NE2 REMARK 470 ARG B 150 NE CZ NH1 NH2 REMARK 470 LYS B 152 CE NZ REMARK 470 GLN B 210 CG CD OE1 NE2 REMARK 470 GLU B 214 CG CD OE1 OE2 REMARK 470 GLU B 245 CD OE1 OE2 REMARK 470 LYS B 311 CD CE NZ REMARK 470 LYS B 316 CG CD CE NZ REMARK 470 LYS B 320 CG CD CE NZ REMARK 470 ARG B 404 NE CZ NH1 NH2 REMARK 470 GLU B 441 CG CD OE1 OE2 REMARK 470 LYS B 455 CD CE NZ REMARK 470 LYS B 488 CE NZ REMARK 470 LYS B 496 CG CD CE NZ REMARK 470 GLN B 527 CG CD OE1 NE2 REMARK 470 LYS B 535 CG CD CE NZ REMARK 470 LEU B 545 CG CD1 CD2 REMARK 470 GLN B 548 CG CD OE1 NE2 REMARK 470 CYS B 558 SG REMARK 470 ARG B 559 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 146 CG OD1 OD2 REMARK 470 MET A 154 SD CE REMARK 470 LYS A 166 CE NZ REMARK 470 LYS A 189 CG CD CE NZ REMARK 470 LYS A 312 CE NZ REMARK 470 LYS A 316 CE NZ REMARK 470 GLU A 441 CG CD OE1 OE2 REMARK 470 LYS A 455 CG CD CE NZ REMARK 470 GLN A 459 CD OE1 NE2 REMARK 470 LEU A 460 CG CD1 CD2 REMARK 470 LYS A 488 CG CD CE NZ REMARK 470 LYS A 496 CG CD CE NZ REMARK 470 GLN A 527 CG CD OE1 NE2 REMARK 470 GLU A 530 CG CD OE1 OE2 REMARK 470 GLU A 534 CG CD OE1 OE2 REMARK 470 LEU A 545 CG CD1 CD2 REMARK 470 GLN A 548 CG CD OE1 NE2 REMARK 470 ARG A 559 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 577 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 809 O HOH B 824 1.59 REMARK 500 OE1 GLN B 349 O HOH B 701 2.07 REMARK 500 OE2 GLU B 242 O HOH B 702 2.09 REMARK 500 O HOH A 723 O HOH A 757 2.09 REMARK 500 O3P PLP B 601 O HOH B 703 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CD1 LEU B 137 OD2 ASP B 151 2656 2.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 170 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG B 170 NE - CZ - NH2 ANGL. DEV. = -4.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR B 138 -156.27 -142.06 REMARK 500 ASP B 146 -78.95 -16.29 REMARK 500 PRO B 176 38.75 -97.54 REMARK 500 VAL B 221 -70.95 -94.74 REMARK 500 ILE B 229 74.36 -111.37 REMARK 500 THR B 329 -76.24 -77.36 REMARK 500 LYS B 391 -106.12 -117.27 REMARK 500 CYS B 395 -126.74 -121.15 REMARK 500 SER B 402 -168.32 -164.04 REMARK 500 PHE B 419 44.56 -93.28 REMARK 500 ARG B 559 42.04 -88.92 REMARK 500 ALA A 174 56.06 -146.48 REMARK 500 PRO A 176 43.01 -102.16 REMARK 500 VAL A 221 -78.21 -93.32 REMARK 500 ILE A 229 73.45 -110.15 REMARK 500 THR A 329 -78.13 -77.74 REMARK 500 LYS A 391 -104.21 -117.30 REMARK 500 CYS A 395 -131.65 -115.31 REMARK 500 SER A 402 -165.51 -168.04 REMARK 500 PHE A 419 45.25 -92.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LEU B 137 TYR B 138 -147.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PLP B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue J4Q B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PLP A 601 DBREF 5QRD B 143 578 UNP P22557 HEM0_HUMAN 145 580 DBREF 5QRD A 143 578 UNP P22557 HEM0_HUMAN 145 580 SEQADV 5QRD MET B 119 UNP P22557 INITIATING METHIONINE SEQADV 5QRD GLY B 120 UNP P22557 EXPRESSION TAG SEQADV 5QRD HIS B 121 UNP P22557 EXPRESSION TAG SEQADV 5QRD HIS B 122 UNP P22557 EXPRESSION TAG SEQADV 5QRD HIS B 123 UNP P22557 EXPRESSION TAG SEQADV 5QRD HIS B 124 UNP P22557 EXPRESSION TAG SEQADV 5QRD HIS B 125 UNP P22557 EXPRESSION TAG SEQADV 5QRD HIS B 126 UNP P22557 EXPRESSION TAG SEQADV 5QRD SER B 127 UNP P22557 EXPRESSION TAG SEQADV 5QRD SER B 128 UNP P22557 EXPRESSION TAG SEQADV 5QRD GLY B 129 UNP P22557 EXPRESSION TAG SEQADV 5QRD VAL B 130 UNP P22557 EXPRESSION TAG SEQADV 5QRD ASP B 131 UNP P22557 EXPRESSION TAG SEQADV 5QRD LEU B 132 UNP P22557 EXPRESSION TAG SEQADV 5QRD GLY B 133 UNP P22557 EXPRESSION TAG SEQADV 5QRD THR B 134 UNP P22557 EXPRESSION TAG SEQADV 5QRD GLU B 135 UNP P22557 EXPRESSION TAG SEQADV 5QRD ASN B 136 UNP P22557 EXPRESSION TAG SEQADV 5QRD LEU B 137 UNP P22557 EXPRESSION TAG SEQADV 5QRD TYR B 138 UNP P22557 EXPRESSION TAG SEQADV 5QRD PHE B 139 UNP P22557 EXPRESSION TAG SEQADV 5QRD GLN B 140 UNP P22557 EXPRESSION TAG SEQADV 5QRD SER B 141 UNP P22557 EXPRESSION TAG SEQADV 5QRD MET B 142 UNP P22557 EXPRESSION TAG SEQADV 5QRD VAL B 221 UNP P22557 ALA 223 CONFLICT SEQADV 5QRD GLY B 579 UNP P22557 EXPRESSION TAG SEQADV 5QRD PRO B 580 UNP P22557 EXPRESSION TAG SEQADV 5QRD GLN B 581 UNP P22557 EXPRESSION TAG SEQADV 5QRD TYR B 582 UNP P22557 EXPRESSION TAG SEQADV 5QRD VAL B 583 UNP P22557 EXPRESSION TAG SEQADV 5QRD THR B 584 UNP P22557 EXPRESSION TAG SEQADV 5QRD THR B 585 UNP P22557 EXPRESSION TAG SEQADV 5QRD TYR B 586 UNP P22557 EXPRESSION TAG SEQADV 5QRD ALA B 587 UNP P22557 EXPRESSION TAG SEQADV 5QRD MET A 119 UNP P22557 INITIATING METHIONINE SEQADV 5QRD GLY A 120 UNP P22557 EXPRESSION TAG SEQADV 5QRD HIS A 121 UNP P22557 EXPRESSION TAG SEQADV 5QRD HIS A 122 UNP P22557 EXPRESSION TAG SEQADV 5QRD HIS A 123 UNP P22557 EXPRESSION TAG SEQADV 5QRD HIS A 124 UNP P22557 EXPRESSION TAG SEQADV 5QRD HIS A 125 UNP P22557 EXPRESSION TAG SEQADV 5QRD HIS A 126 UNP P22557 EXPRESSION TAG SEQADV 5QRD SER A 127 UNP P22557 EXPRESSION TAG SEQADV 5QRD SER A 128 UNP P22557 EXPRESSION TAG SEQADV 5QRD GLY A 129 UNP P22557 EXPRESSION TAG SEQADV 5QRD VAL A 130 UNP P22557 EXPRESSION TAG SEQADV 5QRD ASP A 131 UNP P22557 EXPRESSION TAG SEQADV 5QRD LEU A 132 UNP P22557 EXPRESSION TAG SEQADV 5QRD GLY A 133 UNP P22557 EXPRESSION TAG SEQADV 5QRD THR A 134 UNP P22557 EXPRESSION TAG SEQADV 5QRD GLU A 135 UNP P22557 EXPRESSION TAG SEQADV 5QRD ASN A 136 UNP P22557 EXPRESSION TAG SEQADV 5QRD LEU A 137 UNP P22557 EXPRESSION TAG SEQADV 5QRD TYR A 138 UNP P22557 EXPRESSION TAG SEQADV 5QRD PHE A 139 UNP P22557 EXPRESSION TAG SEQADV 5QRD GLN A 140 UNP P22557 EXPRESSION TAG SEQADV 5QRD SER A 141 UNP P22557 EXPRESSION TAG SEQADV 5QRD MET A 142 UNP P22557 EXPRESSION TAG SEQADV 5QRD VAL A 221 UNP P22557 ALA 223 CONFLICT SEQADV 5QRD GLY A 579 UNP P22557 EXPRESSION TAG SEQADV 5QRD PRO A 580 UNP P22557 EXPRESSION TAG SEQADV 5QRD GLN A 581 UNP P22557 EXPRESSION TAG SEQADV 5QRD TYR A 582 UNP P22557 EXPRESSION TAG SEQADV 5QRD VAL A 583 UNP P22557 EXPRESSION TAG SEQADV 5QRD THR A 584 UNP P22557 EXPRESSION TAG SEQADV 5QRD THR A 585 UNP P22557 EXPRESSION TAG SEQADV 5QRD TYR A 586 UNP P22557 EXPRESSION TAG SEQADV 5QRD ALA A 587 UNP P22557 EXPRESSION TAG SEQRES 1 B 469 MET GLY HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP SEQRES 2 B 469 LEU GLY THR GLU ASN LEU TYR PHE GLN SER MET PHE SER SEQRES 3 B 469 TYR ASP GLN PHE PHE ARG ASP LYS ILE MET GLU LYS LYS SEQRES 4 B 469 GLN ASP HIS THR TYR ARG VAL PHE LYS THR VAL ASN ARG SEQRES 5 B 469 TRP ALA ASP ALA TYR PRO PHE ALA GLN HIS PHE SER GLU SEQRES 6 B 469 ALA SER VAL ALA SER LYS ASP VAL SER VAL TRP CYS SER SEQRES 7 B 469 ASN ASP TYR LEU GLY MET SER ARG HIS PRO GLN VAL LEU SEQRES 8 B 469 GLN ALA THR GLN GLU THR LEU GLN ARG HIS GLY VAL GLY SEQRES 9 B 469 ALA GLY GLY THR ARG ASN ILE SER GLY THR SER LYS PHE SEQRES 10 B 469 HIS VAL GLU LEU GLU GLN GLU LEU ALA GLU LEU HIS GLN SEQRES 11 B 469 LYS ASP SER ALA LEU LEU PHE SER SER CYS PHE VAL ALA SEQRES 12 B 469 ASN ASP SER THR LEU PHE THR LEU ALA LYS ILE LEU PRO SEQRES 13 B 469 GLY CYS GLU ILE TYR SER ASP ALA GLY ASN HIS ALA SER SEQRES 14 B 469 MET ILE GLN GLY ILE ARG ASN SER GLY ALA ALA LYS PHE SEQRES 15 B 469 VAL PHE ARG HIS ASN ASP PRO ASP HIS LEU LYS LYS LEU SEQRES 16 B 469 LEU GLU LYS SER ASN PRO LYS ILE PRO LYS ILE VAL ALA SEQRES 17 B 469 PHE GLU THR VAL HIS SER MET ASP GLY ALA ILE CYS PRO SEQRES 18 B 469 LEU GLU GLU LEU CYS ASP VAL SER HIS GLN TYR GLY ALA SEQRES 19 B 469 LEU THR PHE VAL ASP GLU VAL HIS ALA VAL GLY LEU TYR SEQRES 20 B 469 GLY SER ARG GLY ALA GLY ILE GLY GLU ARG ASP GLY ILE SEQRES 21 B 469 MET HIS LYS ILE ASP ILE ILE SER GLY THR LEU GLY LYS SEQRES 22 B 469 ALA PHE GLY CYS VAL GLY GLY TYR ILE ALA SER THR ARG SEQRES 23 B 469 ASP LEU VAL ASP MET VAL ARG SER TYR ALA ALA GLY PHE SEQRES 24 B 469 ILE PHE THR THR SER LEU PRO PRO MET VAL LEU SER GLY SEQRES 25 B 469 ALA LEU GLU SER VAL ARG LEU LEU LYS GLY GLU GLU GLY SEQRES 26 B 469 GLN ALA LEU ARG ARG ALA HIS GLN ARG ASN VAL LYS HIS SEQRES 27 B 469 MET ARG GLN LEU LEU MET ASP ARG GLY LEU PRO VAL ILE SEQRES 28 B 469 PRO CYS PRO SER HIS ILE ILE PRO ILE ARG VAL GLY ASN SEQRES 29 B 469 ALA ALA LEU ASN SER LYS LEU CYS ASP LEU LEU LEU SER SEQRES 30 B 469 LYS HIS GLY ILE TYR VAL GLN ALA ILE ASN TYR PRO THR SEQRES 31 B 469 VAL PRO ARG GLY GLU GLU LEU LEU ARG LEU ALA PRO SER SEQRES 32 B 469 PRO HIS HIS SER PRO GLN MET MET GLU ASP PHE VAL GLU SEQRES 33 B 469 LYS LEU LEU LEU ALA TRP THR ALA VAL GLY LEU PRO LEU SEQRES 34 B 469 GLN ASP VAL SER VAL ALA ALA CYS ASN PHE CYS ARG ARG SEQRES 35 B 469 PRO VAL HIS PHE GLU LEU MET SER GLU TRP GLU ARG SER SEQRES 36 B 469 TYR PHE GLY ASN MET GLY PRO GLN TYR VAL THR THR TYR SEQRES 37 B 469 ALA SEQRES 1 A 469 MET GLY HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP SEQRES 2 A 469 LEU GLY THR GLU ASN LEU TYR PHE GLN SER MET PHE SER SEQRES 3 A 469 TYR ASP GLN PHE PHE ARG ASP LYS ILE MET GLU LYS LYS SEQRES 4 A 469 GLN ASP HIS THR TYR ARG VAL PHE LYS THR VAL ASN ARG SEQRES 5 A 469 TRP ALA ASP ALA TYR PRO PHE ALA GLN HIS PHE SER GLU SEQRES 6 A 469 ALA SER VAL ALA SER LYS ASP VAL SER VAL TRP CYS SER SEQRES 7 A 469 ASN ASP TYR LEU GLY MET SER ARG HIS PRO GLN VAL LEU SEQRES 8 A 469 GLN ALA THR GLN GLU THR LEU GLN ARG HIS GLY VAL GLY SEQRES 9 A 469 ALA GLY GLY THR ARG ASN ILE SER GLY THR SER LYS PHE SEQRES 10 A 469 HIS VAL GLU LEU GLU GLN GLU LEU ALA GLU LEU HIS GLN SEQRES 11 A 469 LYS ASP SER ALA LEU LEU PHE SER SER CYS PHE VAL ALA SEQRES 12 A 469 ASN ASP SER THR LEU PHE THR LEU ALA LYS ILE LEU PRO SEQRES 13 A 469 GLY CYS GLU ILE TYR SER ASP ALA GLY ASN HIS ALA SER SEQRES 14 A 469 MET ILE GLN GLY ILE ARG ASN SER GLY ALA ALA LYS PHE SEQRES 15 A 469 VAL PHE ARG HIS ASN ASP PRO ASP HIS LEU LYS LYS LEU SEQRES 16 A 469 LEU GLU LYS SER ASN PRO LYS ILE PRO LYS ILE VAL ALA SEQRES 17 A 469 PHE GLU THR VAL HIS SER MET ASP GLY ALA ILE CYS PRO SEQRES 18 A 469 LEU GLU GLU LEU CYS ASP VAL SER HIS GLN TYR GLY ALA SEQRES 19 A 469 LEU THR PHE VAL ASP GLU VAL HIS ALA VAL GLY LEU TYR SEQRES 20 A 469 GLY SER ARG GLY ALA GLY ILE GLY GLU ARG ASP GLY ILE SEQRES 21 A 469 MET HIS LYS ILE ASP ILE ILE SER GLY THR LEU GLY LYS SEQRES 22 A 469 ALA PHE GLY CYS VAL GLY GLY TYR ILE ALA SER THR ARG SEQRES 23 A 469 ASP LEU VAL ASP MET VAL ARG SER TYR ALA ALA GLY PHE SEQRES 24 A 469 ILE PHE THR THR SER LEU PRO PRO MET VAL LEU SER GLY SEQRES 25 A 469 ALA LEU GLU SER VAL ARG LEU LEU LYS GLY GLU GLU GLY SEQRES 26 A 469 GLN ALA LEU ARG ARG ALA HIS GLN ARG ASN VAL LYS HIS SEQRES 27 A 469 MET ARG GLN LEU LEU MET ASP ARG GLY LEU PRO VAL ILE SEQRES 28 A 469 PRO CYS PRO SER HIS ILE ILE PRO ILE ARG VAL GLY ASN SEQRES 29 A 469 ALA ALA LEU ASN SER LYS LEU CYS ASP LEU LEU LEU SER SEQRES 30 A 469 LYS HIS GLY ILE TYR VAL GLN ALA ILE ASN TYR PRO THR SEQRES 31 A 469 VAL PRO ARG GLY GLU GLU LEU LEU ARG LEU ALA PRO SER SEQRES 32 A 469 PRO HIS HIS SER PRO GLN MET MET GLU ASP PHE VAL GLU SEQRES 33 A 469 LYS LEU LEU LEU ALA TRP THR ALA VAL GLY LEU PRO LEU SEQRES 34 A 469 GLN ASP VAL SER VAL ALA ALA CYS ASN PHE CYS ARG ARG SEQRES 35 A 469 PRO VAL HIS PHE GLU LEU MET SER GLU TRP GLU ARG SER SEQRES 36 A 469 TYR PHE GLY ASN MET GLY PRO GLN TYR VAL THR THR TYR SEQRES 37 A 469 ALA HET PLP B 601 16 HET J4Q B 602 15 HET PLP A 601 16 HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETNAM J4Q 4-[(2-METHYLSULFONYLIMIDAZOL-1-YL)METHYL]-1,3-THIAZOLE HETSYN PLP VITAMIN B6 PHOSPHATE FORMUL 3 PLP 2(C8 H10 N O6 P) FORMUL 4 J4Q C8 H9 N3 O2 S2 FORMUL 6 HOH *248(H2 O) HELIX 1 AA1 SER B 144 ASP B 159 1 16 HELIX 2 AA2 GLY B 201 ARG B 204 5 4 HELIX 3 AA3 HIS B 205 GLY B 220 1 16 HELIX 4 AA4 SER B 233 HIS B 247 1 15 HELIX 5 AA5 SER B 257 LEU B 273 1 17 HELIX 6 AA6 HIS B 285 GLY B 296 1 12 HELIX 7 AA7 ASP B 306 LYS B 316 1 11 HELIX 8 AA8 PRO B 339 TYR B 350 1 12 HELIX 9 AA9 GLY B 371 ASP B 376 1 6 HELIX 10 AB1 ILE B 378 ILE B 382 5 5 HELIX 11 AB2 THR B 403 ALA B 414 1 12 HELIX 12 AB3 ALA B 414 PHE B 419 1 6 HELIX 13 AB4 PRO B 424 GLY B 440 1 17 HELIX 14 AB5 GLY B 440 ARG B 464 1 25 HELIX 15 AB6 ASN B 482 GLY B 498 1 17 HELIX 16 AB7 SER B 525 VAL B 543 1 19 HELIX 17 AB8 SER B 568 GLY B 576 1 9 HELIX 18 AB9 SER A 144 ASP A 159 1 16 HELIX 19 AC1 GLY A 201 ARG A 204 5 4 HELIX 20 AC2 HIS A 205 GLY A 220 1 16 HELIX 21 AC3 SER A 233 GLN A 248 1 16 HELIX 22 AC4 SER A 257 LEU A 273 1 17 HELIX 23 AC5 HIS A 285 GLY A 296 1 12 HELIX 24 AC6 ASP A 306 LYS A 316 1 11 HELIX 25 AC7 PRO A 339 TYR A 350 1 12 HELIX 26 AC8 GLY A 371 ASP A 376 1 6 HELIX 27 AC9 ILE A 378 ILE A 382 5 5 HELIX 28 AD1 THR A 403 ALA A 414 1 12 HELIX 29 AD2 ALA A 414 PHE A 419 1 6 HELIX 30 AD3 PRO A 424 GLY A 440 1 17 HELIX 31 AD4 GLY A 440 ARG A 464 1 25 HELIX 32 AD5 ASN A 482 GLY A 498 1 17 HELIX 33 AD6 SER A 525 VAL A 543 1 19 HELIX 34 AD7 ASN A 556 ARG A 560 5 5 HELIX 35 AD8 SER A 568 GLY A 576 1 9 SHEET 1 AA1 4 THR B 167 ARG B 170 0 SHEET 2 AA1 4 PHE B 177 PHE B 181 -1 O GLN B 179 N ASN B 169 SHEET 3 AA1 4 LYS B 189 VAL B 193 -1 O VAL B 191 N ALA B 178 SHEET 4 AA1 4 ILE B 499 TYR B 500 1 O TYR B 500 N SER B 192 SHEET 1 AA2 7 SER B 251 PHE B 255 0 SHEET 2 AA2 7 GLY B 398 SER B 402 -1 O GLY B 398 N PHE B 255 SHEET 3 AA2 7 ILE B 384 THR B 388 -1 N ILE B 385 O ALA B 401 SHEET 4 AA2 7 LEU B 353 ASP B 357 1 N VAL B 356 O ILE B 384 SHEET 5 AA2 7 LYS B 323 GLU B 328 1 N VAL B 325 O PHE B 355 SHEET 6 AA2 7 GLU B 277 ASP B 281 1 N TYR B 279 O ILE B 324 SHEET 7 AA2 7 ALA B 298 PHE B 302 1 O ALA B 298 N ILE B 278 SHEET 1 AA3 3 ILE B 476 ARG B 479 0 SHEET 2 AA3 3 LEU B 515 LEU B 518 -1 O LEU B 516 N ILE B 478 SHEET 3 AA3 3 ALA B 503 ILE B 504 -1 N ILE B 504 O LEU B 515 SHEET 1 AA4 4 VAL A 168 ARG A 170 0 SHEET 2 AA4 4 PHE A 177 HIS A 180 -1 O GLN A 179 N ASN A 169 SHEET 3 AA4 4 LYS A 189 VAL A 193 -1 O LYS A 189 N HIS A 180 SHEET 4 AA4 4 ILE A 499 TYR A 500 1 O TYR A 500 N SER A 192 SHEET 1 AA5 7 SER A 251 PHE A 255 0 SHEET 2 AA5 7 GLY A 398 SER A 402 -1 O GLY A 398 N PHE A 255 SHEET 3 AA5 7 ILE A 384 THR A 388 -1 N GLY A 387 O TYR A 399 SHEET 4 AA5 7 LEU A 353 ASP A 357 1 N VAL A 356 O ILE A 384 SHEET 5 AA5 7 LYS A 323 GLU A 328 1 N VAL A 325 O LEU A 353 SHEET 6 AA5 7 GLU A 277 ASP A 281 1 N TYR A 279 O ALA A 326 SHEET 7 AA5 7 ALA A 298 PHE A 302 1 O ALA A 298 N ILE A 278 SHEET 1 AA6 3 ILE A 476 ARG A 479 0 SHEET 2 AA6 3 LEU A 515 LEU A 518 -1 O LEU A 518 N ILE A 476 SHEET 3 AA6 3 ALA A 503 ILE A 504 -1 N ILE A 504 O LEU A 515 CISPEP 1 TYR B 175 PRO B 176 0 0.27 CISPEP 2 TYR B 506 PRO B 507 0 2.21 CISPEP 3 TYR A 175 PRO A 176 0 4.65 CISPEP 4 TYR A 506 PRO A 507 0 4.25 SITE 1 AC1 15 THR A 420 THR A 421 SER B 257 CYS B 258 SITE 2 AC1 15 PHE B 259 ASN B 262 HIS B 285 GLU B 328 SITE 3 AC1 15 SER B 332 ASP B 357 HIS B 360 THR B 388 SITE 4 AC1 15 LYS B 391 GLY B 397 HOH B 703 SITE 1 AC2 4 TYR A 413 TRP B 570 SER B 573 TYR B 574 SITE 1 AC3 14 SER A 257 CYS A 258 PHE A 259 ASN A 262 SITE 2 AC3 14 HIS A 285 GLU A 328 SER A 332 ASP A 357 SITE 3 AC3 14 HIS A 360 THR A 388 LYS A 391 HOH A 702 SITE 4 AC3 14 THR B 420 THR B 421 CRYST1 127.972 108.831 76.076 90.00 109.15 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007814 0.000000 0.002713 0.00000 SCALE2 0.000000 0.009189 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013914 0.00000